InsidersTradesSigma
Explore the full record of transactions filed by Magnus Olafsson Corfitzen, Chief Executive Officer. Officer active across 2 companies, notably Ascelia Pharma AB. Aggregated, 2 disclosures have been logged. The latest transaction was filed on 25 November 2025 — Purchase. Regulator: FIN-FSA. All data is free.
2 of 2 declarations
Magnus Olafsson Corfitzen is the CEO of Ascelia Pharma AB. He is responsible for the strategic direction of the company and the day-to-day management of operations. With a strong background in the pharmaceutical sector, Magnus is committed to promoting innovation and achieving Ascelia's growth objectives. His leadership is crucial for the development of new treatments and meeting patient needs.